WHAT IS THE TRUE CLINICAL-SIGNIFICANCE OF PLASMA-PROTEIN BINDING DISPLACEMENT INTERACTIONS

被引：62

作者：

SANSOM, LN

EVANS, AM

机构：

[1] School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South, 5000, North Terrace

来源：

DRUG SAFETY | 1995年 / 12卷 / 04期

关键词：

D O I：

10.2165/00002018-199512040-00001

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

[No abstract available]

引用

页码：227 / 233

页数：7

共 28 条

[1]

Sellers E.M., Plasma protein displacement interactions are rarely of clinical significance, Pharmacology, 18, (1979)

[2]

Rowland M., Tozer T., Clinical pharmacokinetics. Concepts and applications, (1989)

[3]

Gibaldi M., Biopharmaceutics and clinical pharmacokinetics, (1991)

[4]

Svensson C.K., Woodruff M.N., Lalka D., Influence of protein binding and use of unbound (free) drug concentrations, Applied pharmacokinetics. Principles of therapeutic drug monitoring, pp. 187-219, (1986)

[5]

Stockley I.H., Drug interactions: a source book of adverse interactions, their mechanisms, clinical importance and management, (1981)

[6]

Hansten P.D., Drug interactions: clinical significance of drug interactions, (1985)

[7]

Prescott L.F., Clinically important drug interactions, Drug treatment, (1987)

[8]

MacKichan J.J., Protein binding displacement interactions. Fact or fiction?, Clin Pharmacokinet, 16, pp. 65-73, (1989)

[9]

du Souich P., Verges J., Erill S., Plasma protein binding and pharmacological response, Clin Pharmacokinet, 24, (1993)

[10]

Rolan P.E., Plasma protein binding displacement interactions — why are they still regarded as clinically important?, Br J Clin Pharmacol, 37, (1994)

← 1 2 3 →